Øyvind Midtvedt

1.7k total citations
45 papers, 886 citations indexed

About

Øyvind Midtvedt is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Øyvind Midtvedt has authored 45 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pathology and Forensic Medicine, 28 papers in Pulmonary and Respiratory Medicine and 7 papers in Rheumatology. Recurrent topics in Øyvind Midtvedt's work include Systemic Sclerosis and Related Diseases (36 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (26 papers) and Pulmonary Hypertension Research and Treatments (9 papers). Øyvind Midtvedt is often cited by papers focused on Systemic Sclerosis and Related Diseases (36 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (26 papers) and Pulmonary Hypertension Research and Treatments (9 papers). Øyvind Midtvedt collaborates with scholars based in Norway, United States and Switzerland. Øyvind Midtvedt's co-authors include Øyvind Molberg, Anna‐Maria Hoffmann‐Vold, Torhild Garen, Cathrine Brunborg, Trond Mogens Aaløkken, May Brit Lund, Jan Tore Gran, Håvard Fretheim, Helle Bitter and Marianne Wallenius and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Øyvind Midtvedt

41 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Øyvind Midtvedt Norway 15 654 519 229 146 146 45 886
Håvard Fretheim Norway 12 539 0.8× 501 1.0× 194 0.8× 84 0.6× 89 0.6× 37 719
I. Castellví Spain 17 277 0.4× 315 0.6× 274 1.2× 93 0.6× 92 0.6× 78 833
Tünde Minier Hungary 16 602 0.9× 222 0.4× 184 0.8× 71 0.5× 217 1.5× 35 731
Ko‐Ron Chen Japan 16 237 0.4× 662 1.3× 248 1.1× 74 0.5× 141 1.0× 39 1.1k
Dimitris Vassilakis Greece 8 469 0.7× 833 1.6× 279 1.2× 52 0.4× 40 0.3× 11 952
Janet Markland Canada 8 358 0.5× 142 0.3× 117 0.5× 85 0.6× 131 0.9× 11 815
Erich M. Gaertner United States 13 223 0.3× 225 0.4× 43 0.2× 52 0.4× 65 0.4× 22 703
Margarida Alves Germany 14 1.0k 1.6× 1.2k 2.3× 481 2.1× 85 0.6× 157 1.1× 37 1.5k
Ingrid Holst Olsen Denmark 11 164 0.3× 149 0.3× 1.2k 5.3× 73 0.5× 62 0.4× 14 1.5k
Hoda Kavosi Iran 14 145 0.2× 199 0.4× 111 0.5× 121 0.8× 40 0.3× 51 636

Countries citing papers authored by Øyvind Midtvedt

Since Specialization
Citations

This map shows the geographic impact of Øyvind Midtvedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Øyvind Midtvedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Øyvind Midtvedt more than expected).

Fields of papers citing papers by Øyvind Midtvedt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Øyvind Midtvedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Øyvind Midtvedt. The network helps show where Øyvind Midtvedt may publish in the future.

Co-authorship network of co-authors of Øyvind Midtvedt

This figure shows the co-authorship network connecting the top 25 collaborators of Øyvind Midtvedt. A scholar is included among the top collaborators of Øyvind Midtvedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Øyvind Midtvedt. Øyvind Midtvedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goni, Elisabetta, Jens Vikse, Marco Lanzillotta, et al.. (2025). Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study. European Journal of Internal Medicine. 143. 106459–106459. 1 indexed citations
2.
Fretheim, Håvard, Øyvind Molberg, Øyvind Midtvedt, et al.. (2023). Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis. Lara D. Veeken. 62(8). 2918–2929. 3 indexed citations
3.
Fretheim, Håvard, Ishita Barua, Mike Oliver Becker, et al.. (2023). OP0236 RISK FACTORS FOR SSc-ILD PROGRESSION USING THE NEW PPF GUIDELINE AND INBUILD PF-ILD CRITERIA. Annals of the Rheumatic Diseases. 82. 156–157. 2 indexed citations
4.
Fretheim, Håvard, Cathrine Brunborg, Cosimo Bruni, et al.. (2023). POS1291 PREDICTION OF MORTALITY IN SSC-ILD DEPENDS ON DEFINITION OF ILD PROGRESSION. Annals of the Rheumatic Diseases. 82. 992–993.
5.
Vikse, Jens, Øyvind Midtvedt, Bjørg‐Tilde Svanes Fevang, et al.. (2023). Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort. Arthritis Research & Therapy. 25(1). 163–163. 5 indexed citations
6.
Fretheim, Håvard, Cathrine Brunborg, Øyvind Midtvedt, et al.. (2022). Gastrointestinal symptom severity and progression in systemic sclerosis. Lara D. Veeken. 61(10). 4024–4034. 11 indexed citations
7.
Murbræch, Klaus, Thor Ueland, Vyacheslav Palchevskiy, et al.. (2022). Serum markers of cardiac complications in a systemic sclerosis cohort. Scientific Reports. 12(1). 4661–4661. 7 indexed citations
8.
9.
Fretheim, Håvard, Brian K. Chung, Espen S. Bækkevold, et al.. (2020). Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial. PLoS ONE. 15(5). e0232739–e0232739. 53 indexed citations
10.
Fretheim, Håvard, Anne‐Kristine Halse, Helle Bitter, et al.. (2020). Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort. Lara D. Veeken. 59(10). 2920–2929. 25 indexed citations
11.
Hoffmann‐Vold, Anna‐Maria, Håvard Fretheim, Anne‐Kristine Halse, et al.. (2019). Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort. American Journal of Respiratory and Critical Care Medicine. 200(10). 1258–1266. 160 indexed citations
12.
Hoffmann‐Vold, Anna‐Maria, S. Samuel Weigt, Vyacheslav Palchevskiy, et al.. (2018). Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis. PLoS ONE. 13(11). e0206545–e0206545. 37 indexed citations
13.
Hoffmann‐Vold, Anna‐Maria, Øyvind Midtvedt, Torhild Garen, et al.. (2017). Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort. The Journal of Rheumatology. 44(4). 459–465. 26 indexed citations
14.
Hoffmann‐Vold, Anna‐Maria, Torhild Garen, Øyvind Midtvedt, et al.. (2016). High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis. CHEST Journal. 150(2). 299–306. 64 indexed citations
15.
Midtvedt, Øyvind, et al.. (2014). En mann i 40-årene med hevelse i begge øyehuler. Tidsskrift for Den norske legeforening. 134(15). 1472–1476. 1 indexed citations
16.
Sveberg, Line, et al.. (2014). Overnight Response to Infliximab in Neurosarcoidosis. Clinical Neuropharmacology. 37(5). 142–148. 16 indexed citations
17.
Hoffmann‐Vold, Anna‐Maria, et al.. (2012). Prevalence of systemic sclerosis in south-east Norway. Lara D. Veeken. 51(9). 1600–1605. 38 indexed citations
18.
Gran, Jan Tore, et al.. (2011). En kvinne med tilbakevendende urticaria, leddsmerter og feber. Tidsskrift for Den norske legeforening. 131(2). 135–136. 6 indexed citations
19.
Midtvedt, Øyvind, et al.. (2010). Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature. Scandinavian Journal of Rheumatology. 40(1). 74–79. 25 indexed citations
20.
Gran, Jan Tore, Øyvind Molberg, & Øyvind Midtvedt. (2005). Patofysiologiske aspekter ved systemisk sklerose. Tidsskrift for Den Norske Laegeforening.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Håvard Fretheim Breakdown of academic impact, for papers by I. Castellví Breakdown of academic impact, for papers by Tünde Minier Breakdown of academic impact, for papers by Ko‐Ron Chen Breakdown of academic impact, for papers by Dimitris Vassilakis Breakdown of academic impact, for papers by Janet Markland Breakdown of academic impact, for papers by Erich M. Gaertner Breakdown of academic impact, for papers by Margarida Alves Breakdown of academic impact, for papers by Ingrid Holst Olsen Breakdown of academic impact, for papers by Hoda Kavosi
Rankless by CCL
2026